National Health Investors, Inc.
Income Statement
| Line Item | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 | FY2010 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $278.7M | $248.5M | $228.9M | $177.5M | $117.8M | $93.3M | $83.7M | $82.6M |
| Cost of Revenue | — | — | — | — | — | — | — | — |
| Gross Profit | — | — | — | — | — | — | — | — |
| Gross Margin | — | — | — | — | — | — | — | — |
| Operating Expenses | ||||||||
| Research & Development | — | — | — | — | — | — | — | — |
| SG&A Expense | $12.2M | $9.8M | $10.5M | $9.1M | $9.3M | $7.8M | $7.6M | $7.8M |
| Operating Income | $197.8M | $161.9M | $150.3M | $103.1M | $79.5M | $72.8M | $69.8M | $61.8M |
| Operating Margin | 71.0% | 65.2% | 65.7% | 58.1% | 67.5% | 78.1% | 83.4% | 74.8% |
| Interest Expense | $46.3M | $43.1M | $37.6M | $26.4M | $9.2M | $3.5M | $3.8M | $1.6M |
| Pretax Income | $151.5M | $118.8M | $126.7M | $103.1M | $76.0M | $67.9M | $59.6M | $61.5M |
| Income Tax Expense | $124.0K | $854.0K | $-583.0K | $118.0K | $118.0K | $267.0K | $96.0K | $82.0K |
| Net Income | $159.4M | $151.5M | $148.9M | $101.6M | $106.2M | $90.7M | $81.1M | $69.4M |
| Net Margin | 57.2% | 61.0% | 65.0% | 57.2% | 90.1% | 97.2% | 96.9% | 84.1% |
| EPS (Basic) | $3.90 | $3.88 | $3.96 | $3.04 | $3.74 | $3.26 | $2.93 | $2.51 |
| EPS (Diluted) | $3.87 | $3.87 | $3.95 | $3.04 | $3.74 | $3.26 | $2.92 | $2.50 |
| Shares Outstanding (Basic) | 40.9M | 39.0M | 37.6M | 33.4M | 28.4M | 27.8M | 27.7M | 27.7M |
| Shares Outstanding (Diluted) | 41.2M | 39.2M | 37.6M | 33.4M | 28.4M | 27.8M | 27.8M | 27.7M |
| Dividends Per Share | $3.80 | $3.60 | $3.40 | $3.08 | $2.90 | $2.86 | $2.72 | $2.36 |